PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Frost & Sullivan Recognizes Japan Stent Technology for Its Pioneering Coronary Stent Design - Frost & Sullivan presents Japan Stent Technology with the 2009 European Frost & Sullivan Award for Enabling Technology for its contributions to advancing localized drug delivery in the coronary care segment
Frost & Sullivan Recognizes Japan Stent Technology for Its Pioneering Coronary Stent Design

 

NewswireToday - /newswire/ - London, United Kingdom, 2010/01/28 - Frost & Sullivan presents Japan Stent Technology with the 2009 European Frost & Sullivan Award for Enabling Technology for its contributions to advancing localized drug delivery in the coronary care segment.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Based on its recent research on the medical devices market, Frost & Sullivan presents Japan Stent Technology with the 2009 European Frost & Sullivan Award for Enabling Technology for its contributions to advancing localized drug delivery in the coronary care segment. The company is on the cutting edge of a new era in medical device care that is witnessing a merging of device and pharmaceutical therapy. Drug-hybrid technologies provide a revolutionary advantage over standard forms of therapy and Japan Stent has both bare-metal stents and drug-eluting stents that are designed effectively in preventing restenosis in arteries.

Restenosis is a major concern in stenting procedures and often a fatal post-surgical complication. Japan Stent has deeply researched this issue to develop a new stent design that can be easily delivered into the artery with minimal endothelial abrasions. Another major difficulty surgeons' face on the operating table is the kinking and flaring behaviour of the metallic wire mesh. Japan Stent's bare metal stents do not kink or flare even at their maximum flexibility. The company's patented drug eluting stent is based on the conventional DLC coating method and diffusion of polymer and drug technology. The device is in its non-clinical study and is expected to get commercialized soon.

Excellent clinical results have corroborated the efficacy of the company's coronary stent along with the salient features such as high radial force and flexibility, minimal stimulus to vascular endothelium and optimization of stent design for all sites. All these breakthrough features of Japan Stent's bare metal stent have culminated in the product being approved with a Conformité Européenne (CE) mark certificate. Regulatory approval of the stent was based on exceptional clinical data obtained in a comprehensive clinical program.

"As the premier bare-metal stent system in the market, Japan Stent Technology's coronary stent lives up to its reputation by truly delivering what other stent systems do not. Its stent system's achievement of receiving the CE mark approval speaks volumes about its capabilities," says Frost & Sullivan Research Analyst Sreevidhya Praveen. "Apparently, this bare metal stent system illustrates exceptional characteristics that will position it well in the approximately $1 billion international bare metal stent market. This eventually lays a platform for Japan Stent's promising passive and drug-eluting coating systems that are currently under non-clinical study."

Japan Stent caters to the various needs of the customers by providing complete solutions for coronary stents. The company's innovations are promoted through close associations with the customers and their needs and requirements are continuously met with. Besides a strong research and development (R&D) team with substantial amount of experience, friendly and active communication within the team, and spontaneously organized meetings when needed, have all helped in generating a positive, creative and team spirit within the organization. The company has major clientele, which include medical equipment manufacturers, trading houses, retail dealers and university laboratories.

Overall, Japan Stent takes pride in being an innovation-oriented company, as the products manufactured are advanced, extremely customized, and innovative. The company contributes to safer and more economical medical treatment by producing unique drug eluting stents and functional surface coating of medical devices.

"Whether the next generations of products in coronary stents would incorporate new drug-polymer combinations or gene and cell therapy is not known," notes Praveen. "However, Japan Stent has the expertise to collaborate with any of those industry innovators."

For these achievements, Japan Stent Technology is the worthy recipient of the 2009 European Frost & Sullivan Award for Enabling Technology for in the coronary care medical devices market. Each year, Frost & Sullivan presents this award to a company that has developed new technologies and/or products or enhanced existing products. The award recognizes the recipient's ability to expand into new applications, create industry standards and get end-users to recognize and transition to the new innovation.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Japan Stent Technology

Japan Stent Technology globally contributes to the medical treatment through the business in Okayama prefecture based on new drug coating stent and functional surface coating of medical devices developed in universities. Founded in 2003, the company has devoted significant resources to bringing a family of proprietary endovascular products to market. These products are focused in the emerging markets of stent technology and chronic occlusions. The company has international standards of competitive design, fabrication, polishing, and medical coating of Stent features for medical instrument surface application technology.

Japan Stent designs and manufactures medical instruments such as stents for coronaria, head arteria carotis, and bile passage and catheters. Its major product includes stents, guidewires and catheters which are customized to the needs of the users. Medical instruments are processed using advanced technologies such as Laser machining, carbon coating and biocompatibility, and surface functionalized polymer coating. Available technologies with Japan Stent include stent designing, fine laser processing, stent medical coating, metal surface polishing, and material surface functionalizing.

With its ISO certified stent design, the company has received grant money from the Ministry of Economy, Trade and Industry of Japan, Okayama Government, NEDO, National Institute of Biomedical Innovation, etc.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Recognizes Japan Stent Technology for Its Pioneering Coronary Stent Design

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Ciara Jamie Connolly 
+44 (0) 207.915.7868 ciara.connolly[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

PMR Releases Report for Next Generation IV Infusion Pumps Market Impact of Existing and Emerging Market 2017-2025
Intubation Market Significant Profits Estimated to be Generated by 2025 Says Persistence Market Research
Medical Tapes Market to Reach US$ 2Bn by 2024 Reports PMR
Global Pyrogen Testing Market Value Expected to Increase to US$ 1.37 Billion by 2024 Says PMR
Huber Needles Market Expected to Reach US$ 55M by 2024 According to PMR
ZOLL Technologies for Improving CPR Quality to be Showcased at NTI 2017
ConfirmMDx Improves Prostate Cancer Diagnosis in African American Men
Biomarker-based Technologies to Disrupt Conventional Diagnosis in Diabetes Management across the Globe Finds Frost & Sullivan
Agfa Specialty Products Announces the Launch of UNIQOAT
Sparta Releases Stratas 3.0 and TrackWise Intake
GE Healthcare Signs Agreement with HealthTrust to Supply Radiopharmaceuticals
GE Introduces CardioGraphe - The World’s First Dedicated Cardiovascular CT System
Frost & Sullivan Lauds ClearFlow’s ACT® Technology as a Transformational Force in Post-operative Cardiothoracic Surgery Protocols
ZOLL Receives Health Canada Approval for Two New Models of AEDS
ZOLL Hospital Wearable Defibrillator Receives Premarket Approval from the FDA

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Persistence Market Research (P) Ltd

Visit  MagLar, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)